Orion Group Holdings, Inc.
ORN
Positions held
Your positionsORN isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $366.89M | Enterprise value | $527.06M | Trailing P/E | 113.25 | Forward P/E | 20.13 |
| PEG | 28.96 | Price / book | 2.23 | Beta | 1.43 | Dividend yield | 0.00% |
| Revenue growth | 8.1% | Earnings growth | — | Gross margin | 11.8% | Operating margin | -0.7% |
| Profit margin | 0.4% | ROE | 2.3% | ROA | 1.1% | Debt / equity | 0.99 |
| Current ratio | 1.52 | Free cash flow | -$20.90M | Analyst recommendation | none | Mean target | $15.32 |
| 52w high | $17.40 | 52w low | $8.08 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $222M | $216M | $233M | $225M | $205M | — |
| Op margin | -0.7% | -0.4% | 1.7% | 2.1% | 1.5% | — |
| Net income | -$4.1M | $4.7M | -$0.2M | $3.3M | $0.8M | — |
| Gross margin | 10.3% | 12.0% | 11.6% | 13.2% | 12.6% | — |
| Gross profit | $22.9M | $25.9M | $27.1M | $29.8M | $25.8M | — |
| Operating income | -$1.5M | -$0.8M | $4.0M | $4.7M | $3.0M | — |
- Revenue +3% vs prior quarter ($222M vs $216M).
- Gross margin 10.3% (was 12% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $852M | $796M | $712M | $748M | — |
| Op margin | 1.4% | 1.1% | -1.2% | -1.7% | — |
| Net income | $2.5M | -$1.6M | -$17.9M | -$12.6M | — |
| Gross margin | 12.4% | 11.4% | 8.7% | 6.8% | — |
| Gross profit | $106M | $91.2M | $61.7M | $50.7M | — |
| Operating income | $12.1M | $8.6M | -$8.2M | -$13.0M | — |
Headlines — watch
• [WARN · fundamentals] Orion Q2 Earnings Miss Estimates on Marine Project Delays, Stock Down
News
2026-10-08 · Orion Group Holdings to Report Third Quarter 2026 Financial Results on Tuesday, October 27, 2026
2026-09-22 · Orion Group Holdings Announces Conference Participation
2026-09-10 · ORYZON to Participate in Upcoming Events in September and October
2026-08-31 · ORYZON Announces Notice of Allowance for U.S. Patent Application Covering Iadademstat Combination With Gilteritinib
2026-08-03 · ORN Q2 Earnings Call Ties Profit Reset to Marine Delays
2026-07-30 · EME Q2 Earnings Beat Estimates on Broad-Based Growth, Stock Up
2026-07-30 · PWR Q2 Earnings Beat on Electric Strength, 2026 View Raised, Stock Up
2026-07-30 · Oppenheimer Adjusts Price Target on Orion Group to $15 From $20, Maintains Outperform Rating
2026-07-30 · Orion Group Q2 Earnings Call Highlights
2026-07-29 · Orion Group Holdings Inc (ORN) Q2 2026 Earnings Call Highlights: Navigating Challenges with ...
2026-07-29 · Orion Q2 Earnings Miss Estimates on Marine Project Delays, Stock Down
Price (daily)
Full chart · RSI · MACD · patterns